<DOC>
	<DOCNO>NCT00765986</DOCNO>
	<brief_summary>Non-small cell lung cancer ( NSCLC ) poor prognosis catch early enough . One factor may impact ability control NSCLC low oxygen level ( hypoxia ) inside tumour . This study use 18F-FAZA PET scan assess whether patient hypoxic tumour monitor change hypoxic area tumour currently available standard treatment . It hypothesize 18F-FAZA PET may predict response treatment , local control , and/or survival NSCLC .</brief_summary>
	<brief_title>Pilot Study 18F-FAZA Assessing Early Functional Response Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy Chemo-radiotherapy</brief_title>
	<detailed_description>Locally advanced NSCLC poor prognosis 5 year overall survival rate 15 % . Tumour hypoxia may impact ability control NSCLC . Using 18F-FAZA PET , study ass patient hypoxic treatment . With information , start individualize patient treatment target hypoxia . The relationship area hypoxia ( 18F-FAZA ) high glucose utilization ( 18F-FDG ) also assess .</detailed_description>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>1 . Patients histologicallyproven , biopsy cytology , unresected lung cancer follow histological type : squamous cell carcinoma ; adenocarcinoma ; undifferentiated large cell carcinoma , nonsmall cell , otherwise specify ( NOS , diagnosis cytology alone ) 2 . Patients American Joint Committee Cancer ( AJCC ) Stage I , II , IIIA , IIIB detectable tumour encompass radiation therapy field , include primary tumour involve regional lymph node . 3 . Patients must deem suitable undergo definitive ( i.e . potentially curable ) chemoradiotherapy radiotherapy treat Physician . 4 . The prescribed radiotherapy dose must minimum 60 Gy 30 fraction 5 . Male female ≥ 18 year age . If female child bear potential outside window 10 day since first day last menstrual period , negative pregnancy test require . 6 . ECOG/Zubrod status 01 7 . Patients must least one measurable lesion ≥ 1 cm CT 8 . Able willing follow instruction comply protocol 9 . Provide write informed consent prior participation study 1 . Patients undergone complete subtotal tumour resection 2 . Patients postresection intrathoracic tumour recurrence 3 . Patients eligible definitive surgery ( patient eligible surgery , surgery proceed eligible trial ) 4 . No distant metastasis , prior chemotherapy , thoracic neck radiotherapy 5 . Evidence small cell histology 6 . Prior concurrent malignancy ( except nonmelanomatous skin cancer ) unless diseasefree least 5 year 7 . Inability lay supine position approximately one hour 8 . Nursing pregnant females 9 . Aged le 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>18F-FAZA</keyword>
	<keyword>18F-FDG</keyword>
	<keyword>Positron Emission Tomography</keyword>
</DOC>